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Abstract
Sirtuin belongs to a family of typical histone deacetylase which regulates the fundamental cellular biological processes
including gene expression, genome stability, mitosis, nutrient metabolism, aging, mitochondrial function, and cell motility.
Michael et. al. reported that B-site mutation (Q167A and H187A) decreased the SIRT2 activity but still the structural changes
were not reported. Hence, we performed 5 ns molecular dynamics (MD) simulation on SIRT2 Apo-form and complexes with
substrate/NAD+ and inhibitor of wild type (WT), Q167A, and H187A. The results revealed that the assembly and disassembly
of C-site induced by presence of substrate/NAD+ and inhibitor, respectively. This assembly and disassembly was mainly due
to the interaction between the substrate/NAD+ and inhibitor and F96 and the distance between F96 and H187 which are
present at the neck of the C-site. MD simulations suggest that the conformational change of L3 plays a major role in
assembly and disassembly of C-site. Our current results strongly suggest that the distinct conformational change of L3 as
well as the assembly and disassembly of C-site plays an important role in SIRT2 deacetylation function. Our study unveiled
the structural changes of SIRT2 in presence of NAD+ and inhibitor which should be helpful to improve the inhibitory
potency of SIRT2.
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Introduction
The posttranslational modification regulates a number of
cellular processes including the modulation of DNA accessibility,
replication and repair, acetylation and deacetylation of proteins.
Acetylated histones are generally correlated well with gene activity,
whereas deacetylated histones are associated with chromatin
structure that is less accessible to transcriptional activation [1].
One of the best post translation modifications is the cleavage of
acetyl group from a-amino group of lysine residues in histone tails
of nucleosomes catalyzed by histone deacetylases (HDACs) family.
So far, four different classes of HDACs have been identified in
humans and ramifications into two groups based on its mechanism
(i) the zinc-dependent or classical HDACs: HDAC 1, 2, 3 and 8
are homologues of reduced potassium dependency (Class I), Class
II includes six subtypes and divided into two subclasses, class IIa
(HDAC 4, 5, 7, 9) and Class IIb (HDAC 6,10) and HDAC 11
comes under Class IV (ii) the nicotinamide adenine dinucleotide
(NAD+) dependent Sir2 proteins (sirtuins, Class III HDAC) [2].
The HDACs and histone acetyltransferases (HATs) regulate the
activity of non-histone protein targets such as p53 (deacetylated by
HDAC1) [3,4] or a-tubulin (by HDAC6 and Sirt2) [5].
Sirtuins are a class of NAD+-dependent deacetylase protein and
ADP-ribose-transferase enzymes homologous to yeast Sir2 protein
[6,7] and evolutionally conserved from bacteria to mammals [8].
Sirtuins have been implicated in the control of diverse biological
processes, such as apoptosis, aging, transcriptional silencing,
chromosomal stability, neurodegeneration, cell cycle progression,
autophagy, growth suppression, inflammation, stress response and
overall cellular metabolism [9–13]. In human, seven distinct
NAD+-dependent Sirtuin enzymes (SIRT1-7) were reported which
are involved in the regulation of neuronal survival. The seven
enzymes (SIRT1-7) shared conserved catalytic core domain of
,275 amino acids but differ in their N- and C- terminal. Indeed,
SIRT1, present in nucleus, has been reported to protect against
neuronal death. Mostly SIRT2 present in the cytoplasm and
nucleus where it associates with microtubules and deacetylates a-
tubulin [14,15] and promotes neurodegeneration. SIRT3, SIRT4
and SIRT5, localized in mitochondria, play a role in energy
metabolism and responses to oxidative stress [16]. A growing body
of evidence implicates that SIRT1 and SIRT2 are important
regulators of neurodegeneration [13,17]. Recent studies find that
SIRT2, a second member of the NAD+-dependent HDAC family,
which is most widely known for its ability to interact with a-tubulin
[14]. The structure of SIRT2 catalytic domain consists of large
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and small domains (Figure. 1). The large domain contains a typical
Rossmann fold, comprises of 6 parallel ß-sheets surrounded by 6
a-helices. The small domain was classified into Zinc (Zn) binding
and helical domains. The Zn binding domain consists of 3 anti-
parallel ß-sheets, one a-helix and Zn2+ was anchored by 4
conserved Cysteine residues (C195, C200, C221, and C224) in all
classes of Sir2-like enzymes and the helical domain comprised of 4
helices, 2 short and 2 long helices. The cofactor-binding (NAD+)
pocket was divided into three regions: adenine ribose moiety of
NAD+ is bound in A-site, nicotinamide ribose moiety in B-site and
C-site, nicotinamide is located deep inside the catalytic pocket
[18]. Small molecules that can modulate sirtuin activity have been
shown to have potential in treating cancer [19,20], Parkinson’s
disease [21], obesity and diabetes [22–25], aging and aging-related
diseases [26] as well as it is a putative therapeutic target for
affecting Huntington disease (HD) mediated transcriptional
dysregualtions.
Michael et. al. experientially proved that the mutations of Q167A
and H187A reduced the SIRT2 deacetylation activity and strongly
suggest that these two residues are key player in the catalysis [18],
but fail to produce the structural changes responsible for activity
deterioration. The molecular dynamics (MD) simulation is a valu-
able tool to investigate a wide range of conformational change and
motional phenomena in biomolecular systems such as proteins and
nucleic acids [27]. MD simulation is an alternative and very
efficacious technique through which one can gather information
regarding the conformational changes of the protein due to the
substrate or inhibitor binding. MD simulation is widely used to
obtain information based on the time-dependent conformational
change that is experimentally inaccessible. In this work, the MD
simulation method was utilized to examine the structure and
functional effect of wild type (WT) and SIRT2 mutant (Q167A
and H187A) in B-site. Totally, nine independent MD simulations
were carried out to obtain the equilibrium trajectories and detailed
analysis of these trajectories suggested that the conformational




Due to the absence of experimentally determined SIRT2
complexes, molecular docking technique was employed to obtain
the complex structures. The atomic coordinates of Apo SIRT2
under the accession code 1J8F [18] was taken from Protein Data
Bank (PDB) [28]. The 2D form of acetylated lysine (substrate), co-
factor (NAD+), and inhibitor were sketched using ChemSketch v12
and converted into 3D format with the help of Discovery Studio
(DS) v2.5. LigandFit was used to understand the hydrogen bond,
hydrophobic interactions between the SIRT2 and small molecules
(substrate, NAD+, and inhibitor). Only the water present in the
active was taken for the docking process and the remaining water
molecules were removed. The hydrogen atoms were added by
applying CHARMm [29] force field to neutralize the receptor, to
attain its suitable orientation in energy minimization. LigandFit
have two methods to find the binding sites (i) protein-ligand
complex, the sole binding site can be found using the ‘docked
ligand’ mode and (ii) absence of protein-ligand complex (known
shape only), employs a cavity finding algorithm for detecting
invaginations of possible candidate active site regions in protein.
Figure 1. SIRT2 Structure properties a) Secondary structural detail, and b) Helical Domain (blue), Zinc binding domain (magenta),
Zinc (gray) and Large domain (red).
doi:10.1371/journal.pone.0059278.g001
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To obtain the most stable energy-minimized conformation of
small molecules, maximum number of 255 conformations were
generated for each by applying Poling algorithm [30] using the
Best Conformation with a constraint of energy value greater than
20 kcalmol21 from the global minimum. We generated the SIRT2
complexes by docking NAD+, acetylated lysine, and inhibitor into
its suitable binding site. The resultant docked complexes with
substrate/NAD+, inhibitor, and Apo-form were used as a starting
structure for MD simulations. The two mutants were constructed
using the interactive DS by replacing Q167 and H187 in the WT
with alanine.
Molecular Dynamics Simulation
MD simulation was performed to gain insight into processes on
an atomistic scale and also to analyze the dynamics behavior of
protein and small molecule in aqueous solution. The classical MD
simulations were performed using GROMACS 3.3 software
package [31–33] by applying leap-frog integration steps to solve
the equations of motion. Herein we used 9 systems for MD
simulations study, each of 5 ns for WT, Q167A and H187A, Apo-
form as well as with substrate/NAD+ and inhibitor. Since the
topology of substrate/NAD+ and inhibitor was not available for
GROMOS96 [34,35] force field, we used the PRODRG server
[36] to generate a set of parameters for bonds and angles based on
the similar force field. No new atom types are included for
substrate/NAD+ and inhibitor so that the atom charges and force
constants are defined in the GROMOS96 force field. The SP3
[37] water model was used to create aqueous environment and the
periodic boundary conditions were applied in all directions. The
system was solvated with SPC water molecules. Before the MD
Table 1. Active site residues in Sirutin 2.
NAD Binding Site Adenosine Binding Site
Ribose Binding
Site Nicotinamide Binding Site
Literature Report N286 E288 R97 A85 Q167 H187 S88 H149 F96 N168 I169 D170
Docking Result
WT-NAD N286 2 2 A85 Q167 H187 2 2 2 N168 I169 D170
Q167A-NAD N286 2 2 A85 2 2 2 2 2 N168 D170
H187A-NAD N286 2 2 A85 Q167 2 2 2 2 N168 I169 D170
WT-Inhibitor 2 2 2 2 Q167 2 2 2 2 2 I169 2
Q167A-Inhbitor 2 2 2 2 A167 H187 2 2 2 2 I169 2
H187A-Inhibitor 2 2 2 2 Q167 2 2 2 2 2 I169 2
doi:10.1371/journal.pone.0059278.t001
Table 2. Summary of nine model systems details for
molecular dynamics simulations calculations.
System* Protein Atoms Water Molecules Na+ Ions
WT_Apo 3038 20486 4
WT_Sub 3110 20443 2
WT_Inhi 3071 20461 4
Q167A_Apo 3032 20495 4
Q167A_Sub 3106 20465 1
Q167A_Inhi 3065 20468 4
H187A_Apo 3032 20496 4
H187A_Sub 3106 20444 1
H187A_Inhi 3065 20467 4
*WT_Apo: Wild type Apo-form, WT_Sub: wild type in presence of NAD and
acetylated lysine; WT_Inhi: wild type in presence of inhibitor; Q167A: Glutamine
mutate to Alanine Apo-form, Q167A_Sub: Glutamine mutate to Alanine in
presence of NAD and acetylated lysine; Q167A_Inhi: Glutamine mutate to
Alanine in presence of inhibitor; H187A: Histidine mutate to Alanine Apo-form,
H187A_Sub: Histidine mutate to Alanine in presence of NAD and acetylated
lysine; H187A_Inhi: Histidine mutate to Alanine in presence of inhibitor.
doi:10.1371/journal.pone.0059278.t002
Figure 2. Root mean square deviation (RMSD) of Ca atoms. a)
Apo_form, b) SIRT2 bound with substrate/NAD+, and c) SIRT2 with
inhibitor.
doi:10.1371/journal.pone.0059278.g002
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simulation, an energy minimization was performed for all the nine
systems (WT and mutants Apo-form, presence of substrate/NAD+
and inhibitor) to remove the poor van der Waal contacts in initial
geometry. After the minimization process, two stages of equilibra-
tion were conducted: (i) 500 ps MD simulation of protein non-
hydrogen atoms with positions restrained to allow the formation of
solvation layers and (ii) another of 2 ns without positional
restriction [38,39]. The second step is important for the systems
to accommodate the thermodynamics conditions imposed in
simulations. After the equilibration stages, nine systems were
subjected to 5 ns MD simulations for further analysis. All MD
simulations applied the constraints algorithms SETTLE [40] and
LINCS [41] for a time step of 2 fs. The LINCS algorithm was
used to constrain all covalent interaction in non-water molecules,
while the SETTLE algorithm was used to constrain bond lengths
and angles in water molecules. A twin range cutoff was set for
long-range interactions: 0.9 nm for van der Waals and 1.4 nm for
electrostatic interactions. For coulomb interactions, the reaction
field correction term [42] was employed, with a dielectric constant
set to 0.8 [43]. Cutoff values of 1.4 and 0.8 Å were used for van
der Waals and coulomb interactions, respectively. A periodic
boundary condition in the isobaric-isothermal (NPT) ensemble
with a constant temperature of 300 K and pressure at 1 atm by
using Berendsen weak coupling [44] time of 0.2 ps was employed
to control the temperature. Finally, the production run was
performed for 5 ns and non-bonded interactions were calculated
as well as the particle mesh Ewald method [45] was applied to
treat the long-range electrostatic interactions. We performed MD
Figure 3. Root mean square fluctuation (RMSF) of Ca atoms. a) Apo_form, b) SIRT2 bound with substrate/NAD+, and c) SIRT2 with inhibitor.
doi:10.1371/journal.pone.0059278.g003
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simulations at 300 K on the Apo-form and complexes to
investigate the dynamic nature of the interactions between the
protein and substrate/NAD+ as well as with inhibitor. The average
structure was calculated from the last 2 ns of the WT as well as
mutants for subsequent structural analyses. All molecular struc-
tures were inspected using the VMD [46] and PyMol [47].
Results and Discussions
Molecular Docking
The molecular docking approach is one of the most reputable
methods in drug discovery process to find the critical interactions
between protein-ligand and protein-protein complexes. Docking
accuracy was measured by the relative true binding mode of small
molecules in receptor active site which determine the quality of
docking methodology. Until now there is a lack of SIRT2 complex
structures, hence molecular docking was carried out using the
SIRT2 Apo-form as a receptor to identify the suitable active site as
well as the binding orientation of substrate/NAD+ and inhibitor.
The apo-form of SIRT2 (PDB: 1J8f) was selected as receptor and
the NAD+ and acetylated lysine were docked in the suitbale
binding pocket which exit between the small and large domain.
The inhibitor was docked in the ‘‘C’’ site of NAD binding pocket
which are mainly responsible for the deacetylase process of SIRT2
[48,49]. The docking process saved top 25 conformations for each
molecule (NAD+, acetylated lysine and inhibitor) based on the
dock score value after the energy minimization using the smart
minimizer method which begins with steepest descent algorithm and
followed by conjugate gradient method. Among the 25 confor-
mation, the complexes which show a high docking score was
selected as initial SIRT2-complex structures for MD simulations.
Based on the literatures, NAD binding pocket residues of SIRT2
was confirmed by multiple sequence analysis of sirtuin family. The
NAD+ and the inhibitor binding site were well defined and
reported in many literatures. Hence to further validate the
complex structures, hydrogen bond interactions between the
SIRT2 and the NAD+ and inhibitor were analyzed (Table 1).
Finally, the observed binding site of SIRT2 was verified by
comparing the volume occupied by NAD+ in the complex
structure of yeast sirtuin (PDB ID: 1SZC) [50]. For inhibitor,
Sir2Af2 bound with NAD, ADPribose and nicotinamide was used
as a reference structure (PDB ID: 1YC2) [51] to identify the
perfect binding site. The comparison of NAD+ and nicotinamide
binding site in the crystal structure of yeast and Af2 Sirtuin shows
a similar binding mode, respectively. The docked substrate/NAD+
and inhibitor are well placed in the SIRT2 active site and showed
all necessary interactions which are reported in the literatures
[50,51]. Finally, the best SIRT2 complexes (File S1) were
subjected to MD simulation to observe its structural changes due
to the binding of substrate/NAD+ and inhibitor.
Molecular Dynamics Simulation
The objective of our MD simulation study was to explore the
assembly of C-site will enhance the deacetylation process in
SIRT2. In order to understand the internal motions and
conformational changes of Apo-form and SIRT2 complexes,
WT and mutants, namely, H187A and Q167A, the 5 ns time scale
MD simulations were performed and analyzed. The summary of
data obtained for 9 SIRT2 systems are presented in Table 2. The
systems stability and fluctuation of the residues were confirmed by
calculating root mean square deviation (RMSD) and root mean
square fluctuation (RMSF) of Ca atom, respectively.
Figure 4. Structural comparison of SIRT2 in presence of substrate/NAD+ a) WT and Q167A and b) WT and H187A. Red, green, and
yellow indicates WT, Q167A, and H187A, respectively. NAD was shown in stick.
doi:10.1371/journal.pone.0059278.g004
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Stability and Flexibility of SIRT2 Structures during
Molecular Dynamics Simulation
An initial evaluation of structural drift provided the stability of
protein in 9 systems by the RMSD analyzes of Ca atoms with
respect to the function of time for WT, Q167A and H187A. The
RMSD plots of WT and mutants during 5 ns simulation
demonstrated the stability of proteins. The RMSD value of WT
Apo-form was varies between 0.32 and 0.33 nm, but in case of
both mutants it showed the variations of 0.28–0.30 nm (Figure. 2).
These data revealed that the stability of Apo-form increased upon
mutations. The inhibitor complexes of WT also have shown
greater deviation when compared with both mutants but in case of
substrate/NAD+ the mutant complexes shows much deviation
than WT (Figure. 2). From the 5 ns production run, last 2 ns
simulation of whole system is fairly stable indicated by small
magnitude of RMSD of the Ca atom which confirmed the protein
stability. Hence, the representative structures for 9 systems were
obtained from last 2 ns of MD simulation trajectory used for
further analyses.
The relative flexibility of each system was characterized by
plotting RMSF for both WT and mutants (Figure. 3). The
WT_Apo shows the values less than 0.2 nm indicates the
minimum fluctuation. Q167A_Apo shows the similar fluctuation
compared with WT_Apo except L4, L11, and L17 where there is
slight increase (.0.2 nm). In case of H187A, the plot shows
significantly larger fluctuation (,0.4 nm) in the conserved loops
(Figure. 3a). In presence of substrate/NAD+ and inhibitor binding
all the systems were stabilized and shown the similar fluctuation.
Conformational Changes in SIRT2 Wild Type Compared
with Mutants
In presence of substrate/NAD+. Comparing the domains
present in WT and Q167A, small shift in the helical and Zn
binding domains and H12 present in the large domain shows
a considerable deviation albeit there is not any considerable
secondary structure change in large and small domains. In-
terestingly part of the two conserved loops (L3 and L8) which
connects the small and large domains was changed into helix
(Figure. 4a).
IncaseofH187A,there isasmallhelix formationinL3,L8aswellas
there is a considerable deviation in the H3 present in the helical
Figure 5. Structural comparison of SIRT2 in presence of inhibitor a) WT and Q167A and b) WT and H187A. Red, green, and yellow
indicates WT, Q167A, and H187A, respectively. Inhibitor was shown in stick.
doi:10.1371/journal.pone.0059278.g005
Figure 6. Superimpose of binding orientation of NAD+ in SIRT2
active site. a) WT with Q167A, deviation of N9A of adenine was 4.14 Å
and b) WT and H187A deviation of N9A of adenine was 1.66 Å. WT-
magenta, Q167A-green, and H187A-yellow.
doi:10.1371/journal.pone.0059278.g006
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domain. The three anti-parallel b-sheets were changed into loop
which indicated a distortion of Zn binding domain (Figure. 4b).
Considerable changes were observed in the H12 present in the large
domain. Here also there is a formation of helix in the two conserved
loops (L3 and L8) connects the small and large domains.
In presence of inhibitor. In Q167A, Zn binding domain was
distorteddue to thechangeof secondarystructureconformation from
anti-parallel ß-sheet into loop. The H3 which was partial distortion in
WT has not shown any changes due Q167A. There was a helix
formation in the conserved L8 and H12 was partially distorted and
shifted above in Q167A. In H187A, H3 was able to distort as in WT
but there isnotanychanges inZnbindingdomain.Formationofhelix
in the conserved loops L3 and L8 and there was an extension of H12
was observed in large domain (Figure. 5).
Comparing the Structural Displacement in NAD+ Binding
Pocket in Wild Type and Mutants
In presence of substrate/NAD+. The WT, NAD+ interacts
with most of the critical residues present in A, B and C-site of
Figure 7. Comparison of C-site deviation due to the presence of NAD+. a) WT_Sub and Q167A, and b) WT_Sub and H187A. The distance are
represented in Å.
doi:10.1371/journal.pone.0059278.g007
Figure 8. Distance between phenyl ring of F96 and phenyl group of NAD and inhibitor was plotted as a function of time in presence
of NAD and inhibitor.
doi:10.1371/journal.pone.0059278.g008
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SIRT2 and forms a strong p-p stacking interaction between the
nicotinamide of NAD+ and phenyl group of F96. The adenosine
moiety of NAD+ shows good interactions with A85, G86, R97,
N286, K287, E288, E323 and C324 which are present in A-site.
Comparing the binding mode of NAD+ in WT and mutants
showed the shift between N9A in NAD+ for Q167A (0.41 nm) and
H187A (0.16 nm) in the adenosine moiety (Figure. 6). Hence we
compute the Ca distance to find the deviation of each residues
present in A-site. In Q167A, the A85 (Ca: 0.233 nm), R86 (Ca:
0.33 nm, CZ: 0.96 nm), N286 (ND2:0.31 nm), K287 (Ca:
0.28 nm), and E288 (Ca: 0.51 nm, CD: 0.63 nm) shows a de-
viation compared with WT. In case of H187A, the R86 shows
much deviation when compared to other A-site residues such as
A85 (Ca: 0.28 nm), N286 (Ca: 0.25 nm, N: 0.25 nm), K287 (Ca:
0.24 nm) and E288 (Ca: 0.25 nm and CD: 0.25 nm). Among all
the residues in A-site, R97 and E288 show a considerable
deviation in both mutations.
The residues 167, 187 present in B-site which helps the
nicotinamide part of NAD+ to enter into the C-site by making
interactions with phosphate groups of NAD+ in WT. The Ca
distance of residues 167 and 187 was calculated between the WT
and mutants; the mutation of Q167 into A shows a Ca deviation of
0.16 nm (Q167A). Due to the mutation of Q167A, H187 showed
a remarkable deviations of 2.56 Å in Ca and 4.72 Å in side chain.
In H187A, the Ca distance between H187 (WT) and A187 in
H187A shows a deviation of 2.06 Å but the Q167 residue not
shows a deviation as expected.
The C-site residues such as S88, F96, H149, N168, D169, and
I170 interacts with nicotinamide part of NAD+ which helps in the
polarization and hydrolysis NAD glycosidic bond. In Q167A, the
Ca deviation of 2.81 Å for S88, 4.34 Å for F96, 4.0 Å for N168,
3.41 Å for I169, and D170 (2.36 nm) (Figure. 7a). In case of
H187A, F96 (Ca 0.26 nm, CZ 6.61 Å), N168 (Ca 2.82 Å, I169
Ca 3.38 Å), D170 (Ca 2.1 Å) deviation was observed when
compared with WT (Figure. 7b). In both type of mutations we
observed that the F96 has shown a huge deviations when
compared with WT.
In WT, after 3 ns the phenyl ring of F96 moves closely to NAD+
from 0.61 to 0.43 nm which is in the range of the aromatic (p-p)
interaction. In Q167A and H187A the distance was gradually
increased to 0.64 and 0.8 nm, respectively (Figure. 8). Hence due
to these mutations the p-p stacking interaction was lost. This
indicates that F96 forms a tight stacking with NAD+ which is one
of the critical interactions in SIRT2 mechanism and plays a vital
role in the formation of C-site pocket. The p-p stacking interaction
may be one of the reasons to reduce the flexibility of substrate/
NAD+ complex and made the structure more stable throughout
the MD simulations.
In presence of inhibitor. In Q167A, A-site residues have
shown only a side chain deviation of 9 Å, 3.47 Å, 3.6 Å, 3 Å for
R41, E267, K231, and E232, respectively. In H187A, only R41,
Figure 9. The total number of intermolecular hydrogen bond interactions exhibited by NAD+ and inhibitor in complex with SIRT2
as a function of time.
doi:10.1371/journal.pone.0059278.g009
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K231, and E232 shows a side chain deviations of 8.07 Å, 6.48 Å,
and 3.98 Å, respectively. In case of B-site, both the mutations does
not shown substantial changes in residue 167 but shows a Ca
deviation of 2.56 Å and 2.06 Å in Q167A and H187A. In both
mutations, the C-site F96 was not able to move away from its
original position as we observed in WT. One of the reasons for
Figure 10. Time trace of Ca-Ca distance between F96 and H187 in WT was plotted as a function of time to highlight the difference in
orientation of the conserved F96 in the L3.
doi:10.1371/journal.pone.0059278.g010
Figure 11. Electrostatic potential map indicates the assembly and disassembly of C-site in presence of NAD+ and inhibitor.
doi:10.1371/journal.pone.0059278.g011
SIRT2 Active Site Assembly by Dynamics Simulation
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F96 rigidity in Q167A was the disability of distortion of H3 present
in the helical domain. In case of H187A, albeit there was
a distortion in H3 but this was moved upwards when compared
with WT. The Ca distance of F96 between WT and Q167 was 13.
57 Å and WT and H187A shows a distance of 11.11 Å.
Hydrogen Bonds Analysis between NAD+ and Inhibitor in
SIRT2
Hydrogen bond (Hbond) plays a crucial role in stabilizing the
complex such as protein-substrate/NAD+, protein-activator, and
protein-inhibitor. Therefore, we analyzed the Hbond framework
for mutated structures as well as WT, to determine the interactions
between protein and small molecules. Hbond between SIRT2 and
substrate/NAD+ and inhibitor was calculated based on the two
criteria: (1) a proton donor (D) and acceptor (A) distance of 3.5 Å
or less and (2) a D-H … A angle of 120o or more. In WT and
mutants, SIRT2 substrate/NAD+ complex have shown a well
conserved Hbond with NAD+ in WT but in both mutations it
shows a less number of Hbonds compared with WT. The
WT_Sub complex have shown approximately 10–12 number of
Hbond but in case of both mutations the numbers of Hbonds was
relatively less which implies that the mutation of B-site was not
able to contact with substrate/NAD+ or inhibitor. The number
and percentage of Hbond occupation of each complex was
evaluated and shown in Figure. 9. Taking into account all the
simulation results shown above disclosed that the NAD+ occupied
a suitable place only in WT and due to both mutations the NAD+
was not able orient in the correct binding pocket. This analysis
showed that B-site mutation affects the NAD+ binding which leads
to suppress of SIRT2 deacetylation process.
Reasons for the Assembly and Disassembly of C-site
From the above analysis it was clear that the mutation in the B-
site would affect the C-site. These changes will be responsible for
the assembly and disassembly of C-site. In case of substrate/NAD+
binding there was a p-p interactions between the phenyl group of
F96 and nicotinamide part of NAD+ but this interaction was
absent in case of mutations (Figure. 8). In WT_Sub complex,
initially 0.7 nm was found between phenyl group of F96 and
NAD+, after 2 ns the distance was maintained at 0.5 nm
throughout the simulations. In case of both mutations we observed
a distance greater than the WT, which confirmed there was less
chance for the formation of p-p stacking interactions between the
phenyl ring of F96 and NAD+. This indicates that F96 moved
away from its original position. In case of Inhibitor binding, WT
shows a average distance of 1.4 nm but Q167A and H187A shows
a distance of ,0.5 which was less than WT.
To affirm the assembly and disassembly of C-site due to B-site
mutations, the Ca distance was calculated between the residue H/
A187 and F96, which was presented at the neck of the C-site. In
presence of substrate, the WT shows a distance of 1.2 nm and
maintained after 3 ns but in both mutations the distance was
nearly 1.5 nm. In presence of inhibitor, the distance between these
two residues was nearly 2 nm in WT but in Q167A and H187A
the distance was less than 0.7 nm and maintained 1.3 nm,
respectively (Figure. 10). The above results clearly insight that
the mutations in B-site will affect the assembly of C-site, which was
responsible for the SIRT2 deacetylation activity. To confirm the
disassembly of C-site due to B-site mutations we compute the
electrostatic potential map.
Electrostatic Potential Surface Analysis
The electrostatic potential surface of protein serves as important
driving force to direct the diffusion of small molecules into its
active site as well as to stabilize the end point interactions between
small molecule and protein. Thus we calculated SIRT2 APBS
electrostatic potential surface [52] in presence of substrate/NAD+
and inhibitor for WT and mutants (Figure. 11). In the WT_Sub
complex, the C-site has strong negative electrical property which
can steadily hold the positive charge of nicotinamide in NAD+.
The electrostatic potential of SIRT2 was retained in presence of
inhibitor in WT but the assembly of C-site was disturbed by
moving the F96 residue (2.07 nm) away from its original position
(Figure. 11a). This reposition makes that the C-site not suitable for
NAD+ binding by disassembly its shape. In both mutations
(Q167A and H187A) the C-site was not able to assembly as in WT
hence it was not able to process the deacetylation of NAD+
(Figure. 11) as effect as in WT. This confirms that the assembly of
C-site was important for SIRT2 deacetylation process. From this
result it was clearly visible that the assembly of C-site will be
critical for the SIRT2 function. Hence, we suggest that this may be
one of the reasons to reduce the SIRT2 activity which were
experimentally proved by Michael et al.
Conclusions
Sirtuins, NAD+-dependent histone deacetylases are interesting
epigenetic regulators due to their actions on histones but also
a regulator of signal transduction networks due to their non-histone
substrates. A mutational study of SIRT2 has provided new insights
into the molecular hindrances responsible for SIRT2 functions.
Hence, MD simulations were performed to provide a structural basis
to activate and inhibit the SIRT2 in presence of substrate/NAD+and
inhibitor. In this study, GROMACS package, GROMOS96 force
field and explicit water molecules were used. The simulation results
suggest the existence of important and functionally relevant
differences between conformational dynamics of SIRT2. In WT
due to NAD binding, large groove between large and small domains
was narrowed which makes suitable place for NAD+ deacetylation
reaction but due to mutations this groove was not able to narrow.
NAD+ and inhibitor binding in WT bring F96 presents in L3 loop
close and far away from H187, which make the assembly and
disassembly of C-site, due to this process the nicotinamide
deacetylation reaction was activated and inhibited, respectively. All
the changes in WT are responsible for the formation of C-site cavity
was absent in case of mutations. In summary, we have shown that the
assembly and disassembly of C-site of NAD binding pocket by 5 ns
time scale is related primarily to the presenceof substrate/NAD+and
inhibitor. Therefore, we propose that any small molecules which
increase the distance between F96 and H187 and make the
disassembly of C-site as well as which can reduce the flexibility of
L3 or shift F96 from its original place will be a good inhibitor for
SIRT2.
Supporting Information
File S1 An archive containing the initial docking
strucutre of WT and NAD, WT and Inhibitor, Q167A
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